These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38566882)

  • 1. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.
    He T; Chen K; Li Y; Luo Z; Luo M; Yang H
    Neuropsychiatr Dis Treat; 2024; 20():725-735. PubMed ID: 38566882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?
    Zhang J; Chen Y; Chen J; Huang X; Wang H; Li Y; Liu W; Feng H
    Neurol Sci; 2021 Mar; 42(3):863-869. PubMed ID: 33438140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and outcomes of myasthenia gravis patients with double positive antibodies against acetylcholine receptor and muscle-specific tyrosine kinase].
    Lu YR; Yu L; Ma Q; Chen P; Qiu L; Ou CY; Lin ZZ; Liu WB
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):942-947. PubMed ID: 35385966
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of rituximab on prognosis in myasthenia gravis: A single-center experience from Turkey].
    Göl MF; Kara F; Boz M; Mutlu A; Karakullukçu S; Boz C
    Ideggyogy Sz; 2022 Sep; 75(9-10):351-359. PubMed ID: 36218113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
    Kwon YN; Woodhall M; Sung JJ; Kim KK; Lim YM; Kim H; Kim JE; Baek SH; Kim BJ; Park JS; Seok HY; Kim DS; Kwon O; Park KH; Sohn E; Bae JS; Yoon BN; Kim NH; Ahn SW; Choi K; Oh J; Park HJ; Shin KJ; Lee S; Park J; Kim SH; Seok JI; Bae DW; An JY; Joo IS; Choi SJ; Nam TS; Kim S; Park KJ; Kwon KH; Waters P; Hong YH
    J Neurol; 2023 Mar; 270(3):1478-1486. PubMed ID: 36396811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
    Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
    Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.
    Martignago S; Fanin M; Albertini E; Pegoraro E; Angelini C
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):103-10. PubMed ID: 19187062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
    Konishi T
    Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting minimal manifestation status induction in myasthenia gravis.
    Li Y; Yang S; Dong X; Li Z; Peng Y; Jin W; Chen D; Zhou R; Jiang F; Yan C; Yang H
    Ther Adv Neurol Disord; 2022; 15():17562864221080520. PubMed ID: 35371293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study.
    Zhao S; Zhang K; Ren K; Lu J; Ma C; Zhao C; Li Z; Guo J
    BMC Neurol; 2021 Nov; 21(1):428. PubMed ID: 34732168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns.
    Stickler DE; Massey JM; Sanders DB
    Clin Neurophysiol; 2005 Sep; 116(9):2065-8. PubMed ID: 16043398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete stable remission and autoantibody specificity in myasthenia gravis.
    Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
    Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
    Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
    Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
    Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
    Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
    Huda S; Woodhall MR; Vincent A; Heckmann JM
    Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status.
    Usmani A; Kwan L; Wahib-Khalil D; Trivedi J; Nations S; Sarode R
    J Clin Apher; 2019 Aug; 34(4):416-422. PubMed ID: 30779438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.